Literature DB >> 8522291

Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer.

J R Jass1.   

Abstract

An understanding of the early morphogenesis of hereditary non-polyposis colorectal cancer is relevant to screening strategies. If most of these cancers were to evolve through the classical adenoma-carcinoma sequence, screening and removal of adenomas at relatively long intervals might be a safe and cost-effective approach. We have reviewed 131 cancers from 117 affected members of 34 such families. One hundred and four cancers were initial symptomatic lesions, eight were cancers detected in asymptomatic screened individuals, one was a synchronous cancer and 18 were metachronous cancers. None of the 131 cancers was a small, superficial type. Residual adenoma (contiguous with cancer) was present in three out of three (100%) in situ cancers, eight out of nine (89%) cancers involving only submucosa, four out of 14 (29%) cancers limited to the muscle coat and 13 of 105 (12%) cancers extending beyond the muscle coat. Twenty-one out of 28 (75%) residual adenomas had a villous component. Only one was flat. Of the eight asymptomatic cancers, seven arose within tubular (two) or tubulovillous adenomas (five). The eighth was not associated with an adenoma but was 35 mm in diameter and extended through the bowel wall. Discrete adenomas (contiguous excluded) were present in 22% of surgical specimens and 31% of specimens from subjects older than 50 years. A relatively high proportion (30%) had a villous component and 43% were at least 10 mm in diameter. Patients with one or more discrete adenomas in their first surgical specimen were more likely to develop multiple cancers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8522291     DOI: 10.1111/j.1365-2559.1995.tb00219.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.

Authors:  M Ilyas; I P Tomlinson; A M Hanby; T Yao; W F Bodmer; I C Talbot
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability.

Authors:  J R Jass; V Pokos; J L Arnold; D S Cottier; P Jeevaratnam; N S Van de Water; P J Browett; I M Winship; M R Lane
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

4.  DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer.

Authors:  H Iino; L Simms; J Young; J Arnold; I M Winship; S I Webb; K L Furlong; B Leggett; J R Jass
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

5.  Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.

Authors:  F E M Rijcken; H Hollema; J H Kleibeuker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

6.  Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families.

Authors:  S H Andersen; E Lykke; M B Folker; I Bernstein; S Holck
Journal:  Fam Cancer       Date:  2007-10-10       Impact factor: 2.375

7.  Clinicopathological features and management of cancers in lynch syndrome.

Authors:  Markku Aarnio
Journal:  Patholog Res Int       Date:  2012-04-30

Review 8.  CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.

Authors:  Ye-Young Rhee; Kyung-Ju Kim; Gyeong Hoon Kang
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

Review 9.  Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors.

Authors:  Vinutna Ganduri; Kruthiga Rajasekaran; Shrimahitha Duraiyarasan; Mayowa A Adefuye; Nisha Manjunatha
Journal:  Cureus       Date:  2022-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.